These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9776380)

  • 41. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
    Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
    J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of vesicular uptake of monoamines by hyperforin.
    Roz N; Mazur Y; Hirshfeld A; Rehavi M
    Life Sci; 2002 Sep; 71(19):2227-37. PubMed ID: 12215370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetic mechanisms of glycine requirement for N-methyl-D-aspartate channel activation.
    Sircar R; Zukin SR
    Brain Res; 1991 Aug; 556(2):280-4. PubMed ID: 1682009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cells.
    Li JH; Bigge CF; Williamson RM; Borosky SA; Vartanian MG; Ortwine DF
    J Med Chem; 1995 May; 38(11):1955-65. PubMed ID: 7783127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyanocobalamin, vitamin B12, depresses glutamate release through inhibition of voltage-dependent Ca2+ influx in rat cerebrocortical nerve terminals (synaptosomes).
    Hung KL; Wang CC; Huang CY; Wang SJ
    Eur J Pharmacol; 2009 Jan; 602(2-3):230-7. PubMed ID: 19073169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain.
    Tavares RG; Tasca CI; Santos CE; Wajner M; Souza DO; Dutra-Filho CS
    Neuroreport; 2000 Feb; 11(2):249-53. PubMed ID: 10674464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective Mechanism for Synthesis of Neurotransmitter Glutamate and its Loading into Synaptic Vesicles.
    Takeda K; Ueda T
    Neurochem Res; 2017 Jan; 42(1):64-76. PubMed ID: 27566324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes.
    Lonart G; Johnson KM
    J Neurochem; 1994 Dec; 63(6):2108-17. PubMed ID: 7964730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of L-2-hydroxyglutaric acid on various parameters of the glutamatergic system in cerebral cortex of rats.
    Junqueira D; Brusque AM; Porciúncula LO; Rotta LN; Ribeiro CA; Frizzo ME; Dutra Filho CS; Wannmacher CM; Wyse AT; Souza DO; Wajner M
    Metab Brain Dis; 2003 Sep; 18(3):233-43. PubMed ID: 14567473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant Yellow.
    Tamura Y; Ogita K; Ueda T
    Neurochem Res; 2014 Jan; 39(1):117-28. PubMed ID: 24248859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the high-affinity uptake of D-[3H]aspartate in rate by L-alpha-aminoadipate and arachidonic acid.
    Lundy DF; McBean GJ
    J Neurol Sci; 1996 Aug; 139 Suppl():1-9. PubMed ID: 8899651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease.
    Westphalen RI; Scott HL; Dodd PR
    J Neural Transm (Vienna); 2003 Sep; 110(9):1013-27. PubMed ID: 12938024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium-dependent release of accumulated glutamate from synaptic vesicles within permeabilized nerve terminals.
    Kish PE; Ueda T
    Neurosci Lett; 1991 Jan; 122(2):179-82. PubMed ID: 1902921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult.
    Koch HP; Chamberlin AR; Bridges RJ
    Mol Pharmacol; 1999 Jun; 55(6):1044-8. PubMed ID: 10347246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rose Bengal analogs and vesicular glutamate transporters (VGLUTs).
    Pietrancosta N; Kessler A; Favre-Besse FC; Triballeau N; Quentin T; Giros B; El Mestikawy S; Acher FC
    Bioorg Med Chem; 2010 Sep; 18(18):6922-33. PubMed ID: 20708942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer.
    Bridges RJ; Stanley MS; Anderson MW; Cotman CW; Chamberlin AR
    J Med Chem; 1991 Feb; 34(2):717-25. PubMed ID: 1671706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BAL modulates glutamate transport in synaptosomes and synaptic vesicles from rat brain.
    Nogueira CW; Rotta LL; Tavares RG; Souza DO; Rocha JB
    Neuroreport; 2001 Mar; 12(3):511-4. PubMed ID: 11234755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles.
    LoPachin RM; Barber DS; He D; Das S
    Toxicol Sci; 2006 Jan; 89(1):224-34. PubMed ID: 16207938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum.
    Kulagina NV; Zigmond MJ; Michael AC
    Neuroscience; 2001; 102(1):121-8. PubMed ID: 11226675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.